Analyst Consensus ?
ConsensusHold15 ratings
Bullish746.7%
Neutral746.7%
Bearish16.6%
Otis Worldwide Corporation · OTIS · FY2025 Q3 · Calendar Q4 2025
Otis Q3 2025: Service Growth Supports Raised Outlook
The quarter provided evidence for a service- and modernization-led growth case: service organic sales grew 6%, modernization orders rose 27%, and management raised full-year guidance. The case remains conditional because New Equipment is still pressured in China, service retention is below its historic level, and tariff and margin risks remain.
Reported Before market openNYSEIndustrials
$24.38B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.05
Consensus $1.01
EPS surprise
+4.0%
Reported versus consensus
Reported revenue
$3.69B
Consensus $3.66B
Revenue surprise
+0.8%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+2.3%
Event window
SPY move
+0.0%
Same window
Abnormal move
+2.2%
Stock minus SPY
Volume
1.9×
Versus trailing sessions
Subsequent drift
-5.2%
Up to 20 sessions
OTISSPY benchmark
Ask FN2 about OTIS FY2025 Q3
Transcript, numbers and history already loaded
Why did OTIS rise 2.3% after beating EPS estimates in FY2025 Q3?What changed in OTIS's guidance and outlook in FY2025 Q3?Give me the bull and bear case for OTIS after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management's stance improved from lowered to raised guidance. Service growth strengthened, modernization orders accelerated from 22% to 27%, and the company reported $100 million-plus of bolt-on M&A through Q3 while continuing China transformation and retention initiatives.
Guidance delta
Raised: full-year EPS guidance was $4.04-$4.08, with low-single-digit growth expected in the Americas and a modest global decline.
Key takeaways
- Service remained the primary growth engine, with 6% organic sales growth and margin expansion.
- Modernization orders rose 27% and backlog grew 22%, supporting a multiyear demand case.
- New Equipment remained pressured in China, while the Americas backlog improved.
Management priorities
- Scale Otis Arise MOD across EMEA and other regions.
- Reach 2.5 million service units by year-end and add maintenance density through bolt-on acquisitions.
- Invest in service excellence, retention programs, dispatch technology, and China transformation savings.
Follow OTIS with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$64.05Current
$75Low
$92.94Average
$119High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 23, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Barclays | Underweight | Underweight | Maintain | Apr 23, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Apr 8, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Apr 1, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 16, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 8, 2025 |
| Argus Research | Buy | Buy | Maintain | May 13, 2024 |
| UBS | Neutral | Neutral | Maintain | Feb 16, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Jan 2, 2024 |
| HSBC | Hold | Hold | Maintain | Apr 19, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 2, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Oct 27, 2022 |
| Berenberg | Buy | Buy | Maintain | Jun 22, 2022 |
Named analyst price targets
Upside is calculated against the persisted current price $64.05. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $77 | $66.68 | +20.2% | Sep 24, 2026 |
| Morgan Stanley | Analyst unavailable | $75 | $72.58 | +17.1% | Aug 10, 2026 |
| RBC Capital | Analyst unavailable | $90 | $73.19 | +40.5% | Jul 28, 2026 |
| Evercore ISI | Alexander Virgo | $95 | $69.92 | +48.3% | Jul 23, 2026 |
| Bernstein | Analyst unavailable | $90 | $70.41 | +40.5% | Jul 23, 2026 |
| Bernstein | Analyst unavailable | $97 | $71.27 | +51.4% | Jun 9, 2026 |
| Morgan Stanley | Analyst unavailable | $88 | $79.52 | +37.4% | Apr 24, 2026 |
| UBS | Analyst unavailable | $105 | $80.87 | +63.9% | Apr 23, 2026 |
| Barclays | Julian Mitchell | $77 | $77.88 | +20.2% | Apr 23, 2026 |
| New Street | Analyst unavailable | $98 | $84.58 | +53.0% | Jan 30, 2026 |
| Wells Fargo | Joseph O'Dea | $92 | $88.14 | +43.6% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $92 | $93.38 | +43.6% | Oct 30, 2025 |
| Wolfe Research | Analyst unavailable | $109 | $90.4 | +70.2% | Oct 8, 2025 |
| Barclays | Julian Mitchell | $91 | $92.12 | +42.1% | Jan 8, 2025 |
| Wells Fargo | Joseph O'Dea | $100 | $92.12 | +56.1% | Jan 7, 2025 |
| Morgan Stanley | Chris Snyder | $97 | $92.43 | +51.4% | Sep 6, 2024 |
| Wells Fargo | Joseph O'Dea | $95 | $91.43 | +48.3% | Jul 25, 2024 |
| Argus Research | John Eade | $108 | $96.21 | +68.6% | May 13, 2024 |
| Melius Research | Rob Wertheimer | $119 | $98.57 | +85.8% | Apr 2, 2024 |
| Barclays | Julian Mitchell | $90 | $98.57 | +40.5% | Apr 2, 2024 |
| Argus Research | John Eade | $102 | $92.41 | +59.3% | Feb 22, 2024 |
| Cowen & Co. | Analyst unavailable | $95 | $84.86 | +48.3% | Feb 2, 2023 |
| Barclays | Analyst unavailable | $81 | $84.56 | +26.5% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $89 | $84.56 | +39.0% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $82 | $84.56 | +28.0% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $71 | $80.25 | +10.9% | Jan 5, 2023 |
| BNP Paribas | Miguel Borrega | $80 | $71.9 | +24.9% | Jul 4, 2022 |
| RBC Capital | Analyst unavailable | $98 | $73.32 | +53.0% | May 4, 2022 |
| Cowen & Co. | Analyst unavailable | $85 | $72.3 | +32.7% | Apr 26, 2022 |
| Barclays | Analyst unavailable | $80 | $73.75 | +24.9% | Apr 26, 2022 |
| Credit Suisse | Analyst unavailable | $81 | $74.6 | +26.5% | Apr 26, 2022 |
Track every rating change on OTIS the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationOtis Worldwide Corporation is a global leader specializing in the manufacturing, installation, and servicing of elevators and escalators, with significant operations in the United States, China, and numerous other international markets. The company's business is organized into two primary divisions: New Equipment and Service. Its New Equipment segment is responsible for the design, fabrication, sale, and fitting of a diverse array of passenger and freight elevators, escalators, and moving walkways, catering to residential and commercial properties, as well as large-scale infrastructure endeavors. Conversely, the Service segment offers extensive maintenance, repair, and modernization services aimed at upgrading existing elevator and escalator systems. Otis maintains a substantial global service footprint, employing approximately 34,000 service technicians across roughly 1,400 branches and offices. The company, established in 1853, is headquartered in Farmington, Connecticut.
Historical context
All OTIS earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the OTIS recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-03T23:00:40.984394+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-03T23:00:40.981660+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.